Roger Jeffs, Director at Axsome Therapeutics, Inc. (AXSM), sold 60,000 shares at $121.27 ($7.3M) on 2025-08-29, disclosed to the SEC on 2025-08-29.
Scheduled sale ($7.3M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $122.30 | 20,000 | $2.4M | 33.5% |
| 2 | $121.60 | 20,000 | $2.4M | 33.3% |
| 3 | $121.27 | 20,000 | $2.4M | 33.2% |
| Total | $121.72 avg | 60,000 | $7.3M | 100% |
| Filing → |
| LQDA | SELL | 2026-05-28 | $400K | — | Filing → |
| LQDA | SELL | 2026-05-26 | $4.6M | — | Filing → |
| LQDA | SELL | 2026-05-20 | $4.4M | — | Filing → |